107 related articles for article (PubMed ID: 29478030)
21. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
[TBL] [Abstract][Full Text] [Related]
22. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis of the microRNA-mRNA network in sebaceous gland carcinoma of the eyelid.
Hirano T; Yunoki T; Furusawa Y; Tabuchi Y; Hayashi A
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179085
[TBL] [Abstract][Full Text] [Related]
24. Early onset sebaceous carcinoma.
Sung D; Kaltreider SA; Gonzalez-Fernandez F
Diagn Pathol; 2011 Sep; 6():81. PubMed ID: 21892948
[TBL] [Abstract][Full Text] [Related]
25. Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
Yunoki T; Tabuchi Y; Hayashi A
Anticancer Res; 2017 Apr; 37(4):1931-1934. PubMed ID: 28373462
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human papillomavirus in eyelid carcinoma among Koreans: a clinicopathological study.
Yang MK; Kim N; Choung H; Kim JE; Khwarg SI
BMC Ophthalmol; 2023 Sep; 23(1):390. PubMed ID: 37752463
[TBL] [Abstract][Full Text] [Related]
28. Circumscribed sebaceous neoplasms: a morphological, immunohistochemical and molecular analysis.
Harvey NT; Tabone T; Erber W; Wood BA
Pathology; 2016 Aug; 48(5):454-62. PubMed ID: 27311873
[TBL] [Abstract][Full Text] [Related]
29. Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma.
Zhang L; Huang X; Zhu X; Ge S; Gilson E; Jia R; Ye J; Fan X
Int J Cancer; 2016 Mar; 138(6):1442-52. PubMed ID: 26437300
[TBL] [Abstract][Full Text] [Related]
30. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis.
Xu S; Moss TJ; Laura Rubin M; Ning J; Eterovic K; Yu H; Jia R; Fan X; Tetzlaff MT; Esmaeli B
Mod Pathol; 2020 Jul; 33(7):1256-1263. PubMed ID: 31937901
[TBL] [Abstract][Full Text] [Related]
31. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma.
Bladen JC; Wang J; Sangaralingam A; Moosajee M; Fitchett C; Chelala C; Beaconsfield M; O'Toole EA; Philpott MP; Ezra DG
Sci Rep; 2018 May; 8(1):7531. PubMed ID: 29760516
[TBL] [Abstract][Full Text] [Related]
33. Sebaceous adenomas of the eyelid and Muir-Torre Syndrome.
Jagan L; Zoroquiain P; Bravo-Filho V; Logan P; Qutub M; Burnier MN
Br J Ophthalmol; 2015 Jul; 99(7):909-13. PubMed ID: 25595178
[TBL] [Abstract][Full Text] [Related]
34. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract][Full Text] [Related]
35. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
36. Comparison of HER2 gene amplification and KRAS alteration in eyelid sebaceous carcinomas with that in other eyelid tumors.
Kwon MJ; Shin HS; Nam ES; Cho SJ; Lee MJ; Lee S; Park HR
Pathol Res Pract; 2015 May; 211(5):349-55. PubMed ID: 25468813
[TBL] [Abstract][Full Text] [Related]
37. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
[TBL] [Abstract][Full Text] [Related]
38. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.
Goldberg M; Rummelt C; Foja S; Holbach LM; Ballhausen WG
Hum Mutat; 2006 Feb; 27(2):155-62. PubMed ID: 16395674
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
[TBL] [Abstract][Full Text] [Related]
40. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
Niu Y; Wang H; Ji J; Lin H; Zhang A
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
